Isavuconazole Activity against Aspergillus lentulus, Neosartorya udagawae, and Cryptococcus gattii, Emerging Fungal Pathogens with Reduced Azole Susceptibility

Multicenter Study of Isavuconazole MIC Distributions and Epidemiological Cutoff Values for Aspergillus spp. for the CLSI M38-A2 Broth Microdilution Method

(2013) A. Espinel-Ingroff et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus 

(2013) Marcin G. Fraczek et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole

(2012) A. Espinel-Ingroff et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Epidemiologic cutoff values for triazole drugs in Cryptococcus gattii: correlation of molecular type and in vitro susceptibility

(2012) Shawn R. Lockhart et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Evaluation of the pharmacokinetics and clinical utility of isavuconazole for treatment of invasive fungal infections

(2012) Joanne Livermore et al.   Expert Opinion on Drug Metabolism & Toxicology

Role of Aspergillus lentulus 14-α Sterol Demethylase (Cyp51A) in Azole Drug Susceptibility

(2011) Emilia Mellado et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India

(2011) A. Chowdhary et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Cryptococcus gattii: an emerging fungal pathogen infecting humans and animals

(2011) Edmond J. Byrnes et al.   MICROBES AND INFECTION

Cryptococcus gattii: a resurgent fungal pathogen

(2011) Vishnu Chaturvedi et al.   TRENDS IN MICROBIOLOGY

The Outbreak of Cryptococcus gattii in Western North America: Epidemiology and Clinical Issues

(2011) Edmond J. Byrnes et al.   Current Infectious Disease Reports

Differential Aspergillus lentulus Echinocandin Susceptibilities Are Fksp Independent

(2010) J. F. Staab et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Antifungal Susceptibilities and Amplified Fragment Length Polymorphism Genotyping of a Worldwide Collection of 350 Clinical, Veterinary, and Environmental Cryptococcus gattii Isolates

(2010) F. Hagen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America

(2010) John R. Perfect et al.   CLINICAL INFECTIOUS DISEASES

Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009)

(2010) Michael A. Pfaller et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Editorial: Assessing the antimicrobial susceptibility of bacteria obtained from animals

(2010) S. Schwarz et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Activated dormantCryptococcus gattiiinfection in a Dutch tourist who visited Vancouver Island (Canada): a molecular epidemiological approach

(2010) Ferry Hagen et al.   MEDICAL MYCOLOGY

UnusualAspergillusspecies in patients with cystic fibrosis

(2010) Françoise Symoens et al.   MEDICAL MYCOLOGY

Isavuconazole: A Comprehensive Review of Spectrum of Activity of a New Triazole

(2010) George R. Thompson et al.   MYCOPATHOLOGIA

Emergence and Pathogenicity of Highly Virulent Cryptococcus gattii Genotypes in the Northwest United States

(2010) Edmond J. Byrnes et al.   PLoS Pathogens

Invasive Aspergillosis Due toNeosartorya udagawae

(2009) Donald C. Vinh et al.   CLINICAL INFECTIOUS DISEASES

Cryptococcus gattii Meningoencephalitis in an Immunocompetent Person 13 Months after Exposure

(2009) A. Georgi et al.   INFECTION

Aspergillus Section Fumigati Typing by PCR-Restriction Fragment Polymorphism

(2009) J. F. Staab et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Correlation of Genotype and In Vitro Susceptibilities of Cryptococcus gattii Strains from the Pacific Northwest of the United States

(2009) N. Iqbal et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Neosartorya udagawae(Aspergillus udagawae), an Emerging Agent of Aspergillosis: How Different Is It fromAspergillus fumigatus?

(2009) J. A. Sugui et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Molecular Evidence That the Range of the Vancouver Island Outbreak ofCryptococcus gattiiInfection Has Expanded into the Pacific Northwest in the United States

(2009) Edmond J. Byrnes III et al.   JOURNAL OF INFECTIOUS DISEASES

Aislamiento de Aspergillus lentulus en España en un paciente crítico con enfermedad pulmonar obstructiva crónica

(2009) Almudena Alhambra et al.   REVISTA IBEROAMERICANA DE MICOLOGIA

Antifungal Susceptibilities among Different Serotypes of Cryptococcus gattii and Cryptococcus neoformans

(2008) G. R. Thompson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Aspergillus Section Fumigati: Antifungal Susceptibility Patterns and Sequence-Based Identification

(2008) L. Alcazar-Fuoli et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Isavuconazole: a new and promising antifungal triazole for the treatment of invasive fungal infections

(2008) Jesús Guinea et al.   Future Microbiology